Advanced Enzyme Technologies Limited has announced strong financial performance for the fiscal year ended March 31, 2026. The company reported a significant increase in annual revenue to ₹7,457.57 million and a net profit of ₹1,736.08 million. Furthermore, the Board has recommended a final dividend of ₹1.35 per share, reflecting the company’s solid financial health and commitment to maximizing long-term shareholder value despite current capital preservation strategies.
Annual Financial Highlights
For the financial year 2025-26, Advanced Enzyme Technologies achieved total revenue from operations of ₹7,457.57 million, compared to ₹6,369.10 million in the previous year. The company’s net profit for the year rose to ₹1,736.08 million, up from ₹1,339.74 million in the prior fiscal year, demonstrating steady growth. The fourth quarter results also showed robust activity, with revenue reaching ₹2,033.67 million.
Dividend and Strategic Outlook
The Board of Directors has recommended a final dividend of 67.5%, amounting to ₹1.35 per equity share (face value of ₹2), pending shareholder approval at the upcoming 37th Annual General Meeting. While the company maintains a healthy financial position, it has opted to defer the declaration of an interim dividend to preserve capital and maintain flexibility for potential strategic investments and corporate actions aimed at long-term value creation.
Leadership and Operational Updates
In key governance developments, the Board approved the re-appointment of Mr. Mukund Madhusudan Kabra as Whole Time Director for a 5-year term effective April 1, 2027. Additionally, Mr. Pradip Bhailal Shah has been appointed as an Additional Director (Independent) for a 5-year term starting June 12, 2026. The company also confirmed the re-appointment of M S K A & Associates LLP as Statutory Auditors for another five-year tenure.
Employee Stock Options and Share Capital
The company successfully allotted 49,350 equity shares under the Employees Stock Options Scheme 2022. This move has increased the paid-up share capital from ₹223.85 million to ₹223.95 million, further aligning employee interests with the growth trajectory of the business.
Source: BSE
